Glycomet: Advanced Glycemic Control for Type 2 Diabetes
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.21 | $36.98 (0%) | 🛒 Add to cart |
| 270 | $0.18 | $55.47 $49.02 (12%) | 🛒 Add to cart |
| 360 | $0.17
Best per pill | $73.96 $61.06 (17%) | 🛒 Add to cart |
Similar products
Glycomet is a widely prescribed oral antidiabetic medication containing metformin hydrochloride, designed to manage blood glucose levels in patients with type 2 diabetes mellitus. As a first-line therapeutic agent, it works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. Its efficacy, safety profile, and long-standing clinical use make it a cornerstone in diabetes management protocols worldwide. Proper usage under medical supervision can significantly reduce the risk of diabetes-related complications.
Features
- Contains metformin hydrochloride as the active ingredient
- Available in immediate-release and extended-release formulations
- Dosage strengths: 500 mg, 850 mg, and 1000 mg tablets
- White to off-white, film-coated, biconvex tablets
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively lowers both fasting and postprandial blood glucose levels
- Reduces hemoglobin A1c (HbA1c) by approximately 1-2%
- Associated with weight neutrality or modest weight loss in most patients
- Demonstrates cardiovascular protective effects in long-term use
- Low risk of hypoglycemia when used as monotherapy
- May improve lipid profiles and reduce cardiovascular risk factors
Common use
Glycomet is primarily indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It may be used as monotherapy or in combination with other oral antidiabetic agents or insulin when glycemic targets are not achieved with metformin alone. The medication is particularly suitable for overweight patients due to its weight-neutral effects and is often prescribed as initial pharmacotherapy upon diabetes diagnosis.
Dosage and direction
The recommended starting dose is 500 mg twice daily or 850 mg once daily, taken with meals to minimize gastrointestinal side effects. Dosage should be titrated gradually based on glycemic control and tolerability, with usual maintenance doses ranging from 1500 mg to 2000 mg per day. The maximum recommended daily dose is 2550 mg administered in divided doses. Extended-release formulations are typically administered once daily with the evening meal. Renal function must be assessed before initiation and regularly during treatment.
Precautions
- Assess renal function before initiation and at least annually during treatment
- Temporarily discontinue prior to iodinated contrast imaging procedures
- Monitor for signs and symptoms of vitamin B12 deficiency
- Use caution in elderly patients and those with hepatic impairment
- Avoid excessive alcohol consumption during treatment
- Regular monitoring of blood glucose and HbA1c levels recommended
Contraindications
- Severe renal impairment (eGFR below 30 mL/min/1.73 m²)
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis
- History of hypersensitivity to metformin or any component of the formulation
- Acute congestive heart failure requiring pharmacological treatment
- Severe hepatic impairment
- Acute conditions that may affect renal function (dehydration, severe infection)
Possible side effects
- Gastrointestinal disturbances: diarrhea, nausea, vomiting, abdominal discomfort
- Metallic taste sensation
- Lactic acidosis (rare but serious)
- Vitamin B12 deficiency with long-term use
- Skin reactions including rash and urticaria
- Headache and dizziness
Drug interaction
- Cationic drugs: cimetidine may increase metformin exposure
- Alcohol: potentiates metformin’s effect on lactate metabolism
- Hypoglycemic agents: enhanced glucose-lowering effect with sulfonylureas or insulin
- Carbonic anhydrase inhibitors: may increase risk of lactic acidosis
- Certain antihypertensive and diuretic agents may affect glucose metabolism
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for the missed one. Maintain regular dosing schedule to ensure consistent glycemic control. Consult healthcare provider if multiple doses are missed.
Overdose
Metformin overdose may result in hypoglycemia and lactic acidosis. Symptoms include nausea, vomiting, diarrhea, abdominal pain, tachycardia, and hypothermia. Lactic acidosis presents with hyperventilation, myalgia, malaise, and somnolence. Treatment involves immediate medical attention, blood glucose monitoring, and supportive care. Hemodialysis may be effective in removing accumulated metformin.
Storage
Store at room temperature (15-30°C) in original container, protected from moisture and light. Keep tightly closed and out of reach of children. Do not use beyond the expiration date printed on packaging. Do not store in bathroom or other humid areas.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting or changing any medication regimen. Individual patient needs may vary, and proper medical supervision is essential for safe and effective diabetes management.
Reviews
Clinical studies consistently demonstrate Glycomet’s efficacy in achieving and maintaining glycemic targets. The UK Prospective Diabetes Study established metformin’s superiority in reducing diabetes-related endpoints and mortality in overweight patients. Real-world evidence supports its long-term safety profile and cardiovascular benefits. Patients typically report satisfactory glucose control with proper dosage titration and management of gastrointestinal side effects during initial treatment phases.